Teacher Retirement System Of Texas Clovis Oncology, Inc. Transaction History

Teacher Retirement System Of Texas

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	SELL	$0.63 - $2.96 $4,662 - $21,904	-7,400 Reduced 28.44%	18,624 $34,000
Q1 2022 May 09, 2022	BUY	$1.43 - $3.14 $6,532 - $14,343	4,568 Added 21.29%	26,024 $53,000
Q4 2021 Feb 10, 2022	BUY	$2.7 - $4.76 $14,793 - $26,080	5,479 Added 34.29%	21,456 $58,000
Q3 2021 Nov 09, 2021	BUY	$4.06 - $5.8 $19,833 - $28,333	4,885 Added 44.04%	15,977 $71,000
Q2 2021 Aug 05, 2021	BUY	$5.02 - $7.05 $55,681 - $78,198	11,092 New	11,092 $64,000
Q3 2018 Nov 09, 2018	SELL	$29.37 - $49.48 $286,122 - $482,034	-9,742 Closed	0 $0
Q2 2018 Aug 06, 2018	SELL	$42.06 - $62.4 $23,259 - $34,507	-553 Reduced 5.37%	9,742 $443,000
Q1 2018 May 08, 2018	SELL	$50.12 - $67.72 $268,091 - $362,234	-5,349 Reduced 34.19%	10,295 $544,000
Q4 2017 Feb 06, 2018	BUY	$57.69 - $84.58 $683,338 - $1 Million	11,845 Added 311.79%	15,644 $1.06 Million
Q3 2017 Nov 06, 2017	BUY	$67.17 - $84.81 $255,178 - $322,193	3,799	3,799 $313,000

166

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

Get notified when there are updates to the investment portfolio of Teacher Retirement System Of Texas, based on Form 13F filings with the SEC.

Stay updated on Teacher Retirement System Of Texas with notifications on news.